Meeting
2019 ASCO Annual Meeting
Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using TERT promoter mutation-specific droplet digital PCR assays.
Authors
Christine Cordova
National Institutes of Health, Bethesda, MD
Christine Cordova , Mahrukh M. Syeda , Broderick Corless , Jennifer M. WIGGINS , Amie Patel , Sylvia Christine Kurz , Malcolm Delara , Zacharia Sawaged , Minerva Utate , Dimitris Placantonakis , John Golfinos , Jessica Schafrick , Joshua Seth Silverman , Rajan Jain , Matija Snuderl , David Zagzag , Yongzhao Shao , George Alan Karlin-Neumann , David Polsky , Andrew S. Chi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2026)
DOI
10.1200/JCO.2019.37.15_suppl.2026
Abstract #
2026
Poster Bd #
215
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.
First Author: Maxime Fontanilles
Poster
2022 ASCO Annual Meeting
Population-based retrospective analysis of response assessment criteria in patients with glioblastoma.
First Author: Parandoush Abbasian
Poster
2018 ASCO Annual Meeting
Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma.
First Author: Michael Weller
First Author: John Lloyd Gainer